COYA (Coya Therapeutics) FCF Margin %: -3,022.95% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COYA Coya Therapeutics Inc COYA
49 GF Score
Price $4.39
GF Value $6.54
Valuation Significantly Undervalued
View Full Analysis

What is Coya Therapeutics FCF Margin %?

Coya Therapeutics COYA -3.10% 49 FCF Margin % is -3,022.95% as of Jun. 2026. GuruFocus rates COYA with a GF Score™ of 49/100 and a GF Value™ of $6.54 (Significantly Undervalued). Among 960 Biotechnology companies, Coya Therapeutics ranks worse than 60.73% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Coya Therapeutics's Free Cash Flow for the three months ended in Jun. 2026 was $-7.38 Mil. Coya Therapeutics's Revenue for the three months ended in Jun. 2026 was $0.24 Mil. Therefore, Coya Therapeutics's FCF Margin % for the quarter that ended in Jun. 2026 was -3,022.95%.

As of today, Coya Therapeutics's current FCF Yield % is -15.27%.

The historical rank and industry rank for Coya Therapeutics's FCF Margin % or its related term are showing as below:

COYA' s FCF Margin % Range Over the Past 10 Years
Min: -289.5   Med: -186.42   Max: -135.15
Current: -196.07

During the past 6 years, the highest FCF Margin % of Coya Therapeutics was -135.15%. The lowest was -289.50%. And the median was -186.42%.

COYA's FCF Margin % is ranked worse than
60.73% of 960 companies
in the Biotechnology industry
Industry Median: -76.29 vs COYA: -196.07

Coya Therapeutics FCF Margin % Related Terms

Coya Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Coya Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coya Therapeutics FCF Margin % Chart

Coya Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -186.42 -289.50 -135.15

Coya Therapeutics Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,520.12 -31.73 -25.43 -2,473.71 -3,022.95

COYA vs ONCY, GUTS, SEER: FCF Margin % Comparison

For the Biotechnology subindustry, Coya Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coya Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coya Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Coya Therapeutics's FCF Margin % falls into.


COYA
49GF Score
Coya Therapeutics Inc COYA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coya Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Coya Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.739/7.946
=-135.15 %

Coya Therapeutics's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-7.376/0.244
=-3,022.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -3,022.95% mean?
Coya Therapeutics (COYA) has a FCF Margin % of -3,022.95% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Coya Therapeutics and its competitors. According to the industry distribution chart, Coya Therapeutics ranks #583 out of 960 companies in the Biotechnology industry, placing it in the top 60.7%.
Is Coya Therapeutics' FCF Margin % too high?
Coya Therapeutics' current FCF Margin % is -3,022.95%. Based on the distribution chart, Coya Therapeutics ranks #583 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Coya Therapeutics has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coya Therapeutics' FCF Margin % compare to ONCY and GUTS?
According to the Biotechnology industry distribution chart, Coya Therapeutics ranks #583 out of 960 companies for FCF Margin %. This places Coya Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Coya Therapeutics and its competitors. Coya Therapeutics's current FCF Margin % is -3,022.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coya Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Coya Therapeutics (COYA) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.54, compared to a current price of $4.39 — trading 32.9% below its estimated fair value. The current FCF Margin % is -3,022.95%. Coya Therapeutics' overall GF Score™ is 49/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Coya Therapeutics (COYA), the current FCF Margin % is -3,022.95% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coya Therapeutics (COYA) Overvalued in 2026?

Based on GuruFocus' analysis, Coya Therapeutics stock appears to be undervalued. The current stock price of $4.39 is trading 32.9% below its estimated GF Value™ of $6.54. GuruFocus considers Coya Therapeutics to be Significantly Undervalued.

Key valuation signals for COYA:

  • FCF Margin %: -3,022.95%
  • GF Value™: $6.54 vs. price of $4.39 (32.9% below fair value)
  • GF Score™: 49/100

No single metric tells the full story. See the COYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coya Therapeutics Business Description

Address 5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
49GF Score

Get the complete analysis for COYA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.39
Price
$6.54
GF Value